Hemophilia B: molecular pathogenesis and mutation analysis-Reference-Cited by-同舟云学术

Hemophilia B: molecular pathogenesis and mutation analysis

Published:2015-05-18 Issue:7 Volume:13 Page:1184-1195
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Goodeve A. C.¹

Affiliation:

1. Haemostasis Research Group Department of Cardiovascular Science Sheffield Children's NHS Foundation Trust University of Sheffield and Sheffield Diagnostic Genetics Service Sheffield UK

Funder

National Institutes for Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.12958

Reference100 articles.

1. Christmas Disease

2. Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database

3. UKHCDO.UK National Haemophilia Database Bleeding Disorder Statistics for 2013–2014http://www.ukhcdo.org/annReport.htm. Accessed 2 February 2015.

4. Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)

5. A study of variations in the reported haemophilia B prevalence around the world

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emicizumab as a Promising Form of Therapy for Type A Hemophilia - AReview of Current Knowledge from Clinical Trials;Current Protein & Peptide Science;2024-11

2. The genetic analysis of eight families with hemophilia B in Mongolia: Identification of two novel mutation;Molecular Genetics & Genomic Medicine;2024-09

3. Current developments of gene therapy in human diseases;MedComm;2024-08-16

4. Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy;Current Gene Therapy;2024-08

5. Successful immunosuppressive drug‐free immune tolerance induction in hemophilia B with inhibitor and anaphylaxis to factor IX: A case report;Clinical Case Reports;2024-08